Molecular mechanisms of endothelial hyperpermeability: Implications in inflammation

Expert Reviews in Molecular Medicine

Volumn 11, Issue , 2009, Pages

  Kumar, Puneet ^a   Shen, Qiang ^a   Pivetti, Christopher D ^a   Lee, Eugene S ^a   Wu, MacK H ^a   Yuan, Sarah Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CAPILLARY PERMEABILITY; CELL JUNCTION; CYTOSKELETON; HUMAN; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CAPILLARY PERMEABILITY; CYTOSKELETON; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERCELLULAR JUNCTIONS; MODELS, BIOLOGICAL;

EID: 69149101976     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399409001112     Document Type: Review

References (154)

1. Bauer, P.M. et al. (2005) Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 102, 204-209 (Pubitemid 40094453)
2. Gratton, J.P., Bernatchez, P. and Sessa, W.C. (2004) Caveolae and caveolins in the cardiovascular system. Circulation Research 94, 1408-1417 (Pubitemid 38780313)
3. Lin, M.I. et al. (2007) Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Research 67, 2849-2856 (Pubitemid 46548975)
4. Razani, B. et al. (2001) Caveolin-1 null mice are viable but showevidence of hyperproliferative and vascular abnormalities. Journal of Biological Chemistry 276, 38121-38138
5. Mehta, D. and Malik, A.B. (2006) Signaling mechanisms regulating endothelial permeability. Physiological Reviews 86, 279-367
6. Dvorak, A.M. et al. (1996) The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. Journal of Leukocyte Biology 59, 100-115 (Pubitemid 26054596)
7. Curry, F.E. and Adamson, R.H. (1999) Transendothelial pathways in venular microvessels exposed to agents which increase permeability: the gaps in our knowledge. Microcirculation 6, 3-5
8. Dvorak, A.M. (2005) Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle. Chemical Immunology and Allergy 85, 185-204
9. Iyer, S. et al. (2004) VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function. American Journal of Physiology - Lung Cellular and Molecular Physiology 286, L1143-1153 (Pubitemid 38656649)
10. Xiao, K. et al. (2005) p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Molecular Biology of the Cell 16, 5141-5151 (Pubitemid 41566827)
11. Esser, S. et al. (1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. Journal of Cell Science 111, 1853-1865 (Pubitemid 28370530)
12. Dejana, E. (2004) Endothelial cell-cell junctions: happy together. Nature Reviews Molecular Cell Biology 5, 261-270
13. Tiruppathi, C. et al. (2006) Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation 13, 693-708 (Pubitemid 44688424)
14. Yuan, S.Y. (2002) Protein kinase signaling in the modulation of microvascular permeability. Vascular Pharmacology 39, 213-223
15. Yuan, S.Y. et al. (2007) Microvascular permeability in diabetes and insulin resistance. Microcirculation 14, 363-373 (Pubitemid 47050028)
16. Isshiki, M. et al. (1998) Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proceedings of the National Academy of Sciences of the United States of America 95, 5009-5014
17. Maekawa, M. et al. (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895-898 (Pubitemid 29381991)
18. Mehta, D., Rahman, A. and Malik, A.B. (2001) Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. Journal of Biological Chemistry 276, 22614-22620
19. Verin, A.D. et al. (2000) Role of ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction. American Journal of Physiology - Lung Cellular and Molecular Physiology 279, L360-370
20. Stasek, J.E., Jr, Patterson, C.E. and Garcia, J.G. (1992) Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. Journal of Cellular Physiology 153, 62-75
21. Sandoval, R. et al. (2001) Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions. Journal of Physiology 533, 433-445 (Pubitemid 32519999)
22. Clarke, H., Soler, A.P. and Mullin, J.M. (2000) Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. Journal of Cell Science 113 (Pt 18), 3187-3196
23. Aramoto, H. et al. (2004) Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. American Journal of Physiology - Heart and Circulatory Physiology 287, H1590-1598 (Pubitemid 39313263)
24. Bates, D.O. and Curry, F.E. (1997) Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. American Journal of Physiology 273, H687-694
25. Breslin, J.W. et al. (2003) VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. American Journal of Physiology - Heart and Circulatory Physiology 284, H92-H100 (Pubitemid 36076274)
26. Lal, B.K. et al. (2001) VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvascular Research 62, 252-262 (Pubitemid 33027911)
27. Varma, S. et al. (2002) p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvascular Research 63, 172-178 (Pubitemid 34971633)
28. Wu, H.M. et al. (1999) Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. American Journal of Physiology 276, H535-542 (Pubitemid 29100622)
29. Stockton, R.A., Schaefer, E. and Schwartz, M.A. (2004) p21-activated kinase regulates endothelial permeability through modulation of contractility. Journal of Biological Chemistry 279, 46621-46630 (Pubitemid 39518307)
30. Wu, M.H. et al. (2003) Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor. Journal of Physiology 552, 691-699 (Pubitemid 37428413)
31. Gavard, J. and Gutkind, J.S. (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nature Cell Biology 8, 1223-1234 (Pubitemid 44660587)
32. Eliceiri, B.P. et al. (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Molecular Cell 4, 915-924 (Pubitemid 30054898)
33. Birukov, K.G. et al. (2001) Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). Journal of Biological Chemistry 276, 8567-8573
34. Wu, M.H., Ustinova, E. and Granger, H.J. (2001) Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. Journal of Physiology 532, 785-791 (Pubitemid 32427891)
35. Shajahan, A.N. et al. (2004) Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells. Journal of Biological Chemistry 279, 20392-20400 (Pubitemid 38623486)
36. Miao, H. et al. (2002) Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. Journal of Cell Science 115, 2199-2206 (Pubitemid 34746385)
37. Mammoto, A., Mammoto, T. and Ingber, D.E. (2008) Rho signaling and mechanical control of vascular development. Current Opinion in Hematology 15, 228-234 (Pubitemid 351507576)
38. Breslin, J.W. et al. (2006) Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage. American Journal of Physiology - Heart and Circulatory Physiology 290, H741-750
39. Breslin, J.W. and Yuan, S.Y. (2004) Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. American Journal of Physiology - Heart and Circulatory Physiology 286, H1057-1062 (Pubitemid 38248621)
40. Sun, H. et al. (2006) Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 13, 237-247
41. van Nieuw Amerongen, G.P. et al. (2000) Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circulation Research 87, 335-340
42. Patil, S.B. and Bitar, K.N. (2006) RhoA- and PKC-alpha-mediated phosphorylation of MYPT and its association with HSP27 in colonic smooth muscle cells. American Journal of Physiology -Gastrointestinal and Liver Physiology 290, G83-95
43. Garcia, J.G. et al. (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. Journal of Clinical Investigation 108, 689-701 (Pubitemid 32906197)
44. Liu, F. et al. (2002) Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB Journal 16, 950-962 (Pubitemid 34753501)
45. Kouklis, P. et al. (2004) Cdc42 regulates the restoration of endothelial barrier function. Circulation Research 94, 159-166 (Pubitemid 38197447)
46. Moore, T.M. et al. (1998) Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. American Journal of Physiology 275, L203-222
47. Lampugnani, M.G. et al. (1991) The role of integrins in the maintenance of endothelial monolayer integrity. Journal of Cell Biology 112, 479-490 (Pubitemid 21926002)
48. Hill, S.J. et al. (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacological Reviews 49, 253-278 (Pubitemid 27414915)
49. Parsons, M.E. and Ganellin, C.R. (2006) Histamine and its receptors. British Journal of Pharmacology 147 Suppl 1, S127-135 (Pubitemid 43077270)
50. Clough, G.F., Bennett, A.R. and Church, M.K. (1998) Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. British Journal of Dermatology 138, 806-814 (Pubitemid 28231521)
51. Yuan, S.Y. (2000) Signal transduction pathways in enhanced microvascular permeability. Microcirculation 7, 395-403
52. Wu, M.H., Yuan, S.Y. and Granger, H.J. (2005) The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules. Journal of Physiology 563, 95-104 (Pubitemid 40340369)
53. Guo, M. et al. (2008) VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. American Journal of Physiology - Cell Physiology 294, C977-984 (Pubitemid 351507915)
54. Shasby, D.M. et al. (2002) Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. American Journal of Physiology - Lung Cellular and Molecular Physiology 282, L1330-1338 (Pubitemid 34654590)
55. Bogatcheva, N.V., Garcia, J.G. and Verin, A.D. (2002) Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry 67, 75-84
56. Borbiev, T. et al. (2003) Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. American Journal of Physiology - Lung Cellular and Molecular Physiology 285, L43-54 (Pubitemid 36736467)
57. Birukova, A.A. et al. (2004) Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB Journal 18, 1879-1890 (Pubitemid 39602273)
58. Holinstat, M. et al. (2003) Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. Journal of Biological Chemistry 278, 28793-28798 (Pubitemid 36935789)
59. Grand, R.J., Turnell, A.S. and Grabham, P.W. (1996) Cellular consequences of thrombin-receptor activation. The Biochemical Journal 313, 353-368 (Pubitemid 26030120)
60. Senger, D.R. et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985
61. Weis, S.M. and Cheresh, D.A. (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437, 497-504 (Pubitemid 41613541)
62. Takahashi, H. et al. (2004) A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. Journal of Biological Chemistry 279, 46304-46314 (Pubitemid 39491626)
63. Zachary, I. (2003) VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochemical Society Transactions 31, 1171-1177
64. Behzadian, M.A. et al. (2003) VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB Journal 17, 752-754
65. Kelly, M., Hwang, J.M. and Kubes, P. (2007) Modulating leukocyte recruitment in inflammation. Journal of Allergy and Clinical Immunology 120, 3-10 (Pubitemid 46990511)
66. Kubes, P. (2002) The complexities of leukocyte recruitment. Seminars in Immunology 14, 65-72
67. Liu, Y. et al. (2004) Regulation of leukocyte transmigration: cell surface interactions and signaling events. Journal of Immunology 172, 7-13 (Pubitemid 38020448)
68. Rao, R.M. et al. (2005) Emerging topics in the regulation of leukocyte transendothelial migration. Microcirculation 12, 83-89 (Pubitemid 40450620)
69. Rao, R.M. et al. (2007) Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation Research 101, 234-247 (Pubitemid 47344073)
70. Rosenkranz, A.R. and Mayadas, T.N. (1999) Leukocyte-endothelial cell interactions - lessons from knockout mice. Experimental Nephrology 7, 125-136 (Pubitemid 29210175)
71. Zarbock, A. and Ley, K. (2008) Mechanisms and consequences of neutrophil interaction with the endothelium. American Journal of Pathology 172, 1-7 (Pubitemid 351186361)
72. Sarelius, I.H. et al. (2006) Macromolecule permeability of in situ and excised rodent skeletal muscle arterioles and venules. American Journal of Physiology - Heart and Circulatory Physiology 290, H474-480
73. Yuan, S.Y. et al. (2002) Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circulation Research 90, 1214-1221 (Pubitemid 34786907)
74. Tinsley, J.H. et al. (2002) Src-dependent, neutrophil-mediated vascular hyperpermeability and beta-catenin modification. American Journal of Physiology - Cell Physiology 283, C1745-1751 (Pubitemid 35340607)
75. Chiba, Y. et al. (2001) Activation of rho is involved in the mechanism of hydrogen-peroxide-induced lung edema in isolated perfused rabbit lung. Microvascular Research 62, 164-171 (Pubitemid 32885703)
76. Sumagin, R., Lomakina, E. and Sarelius, I.H. (2008) Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. American Journal of Physiology - Heart and Circulatory Physiology 295, H969-H977
77. Usatyuk, P.V. et al. (2003) Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function. American Journal of Physiology - Lung Cellular and Molecular Physiology 285, L1006-1017 (Pubitemid 37310090)
78. Usatyuk, P.V. et al. (2003) Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxidants and Redox Signalling 5, 723-730 (Pubitemid 37462055)
79. Blackwell, T.S. and Christman, J.W. (1997) The role of nuclear factor-kappa B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 17, 3-9 (Pubitemid 127500814)
80. Reutershan, J. and Ley, K. (2004) Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Critical Care 8, 453-461 (Pubitemid 40073680)
81. Hu, G. et al. (2008) Intercellular adhesion molecule- 1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circulation Research 102, e120-131
82. Bhatia, M. and Moochhala, S. (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. Journal of Pathology 202, 145-156 (Pubitemid 38208651)
83. Groeneveld, A.B. (2002) Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vascular Pharmacology 39, 247-256
84. Hinshaw, L.B., Jordan, M.M. and Vick, J.A. (1961) Histamine release and endotoxin shock in the primate. Journal of Clinical Investigation 40, 1631-1637
85. Nagy, S. (1990) The role of histamine release in shock. Acta Physiologica Hungarica 76, 3-12
86. Breil, I. et al. (1997) Effects of bradykinin, histamine and serotonin on pulmonary vascular resistance and permeability. Acta Physiologica Scandinavica 159, 189-198 (Pubitemid 27104505)
87. Bauer, T.T. et al. (2000) Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 55, 46-52 (Pubitemid 30248778)
88. Hamacher, J. et al. (2002) Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 166, 651-656 (Pubitemid 34971845)
89. Windsor, A.C. et al. (1993) Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. Journal of Clinical Investigation 91, 1459-1468 (Pubitemid 23127347)
90. Geiser, T. et al. (2001) Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism. American Journal of Respiratory and Critical Care Medicine 163, 1384-1388 (Pubitemid 32506603)
91. Gilmont, R.R. et al. (1998) Effects of glutathione depletion on oxidant-induced endothelial cell injury. Journal of Surgical Research 80, 62-68 (Pubitemid 28507640)
92. Wang, Q. et al. (2007) Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radical Biology and Medicine 43, 1048-1060 (Pubitemid 47302653)
93. Aktan, A. and Yalcin, A. (1998) Ischemia reperfusion injury, reactive oxygen metabolites, and the Surgeon. Turkish Journal of Medical Sciences 28, 1-5
94. Chua, C.C., Hamdy, R.C. and Chua, B.H. (1998) Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radical Biology and Medicine 25, 891-897 (Pubitemid 28538554)
95. Abumiya, T. et al. (2005) Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats. Brain Research 1049, 95-103 (Pubitemid 40814579)
96. Godzich, M. et al. (2006) Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB Journal 20, 1519-1521
97. Nosal'ova, V. et al. (2008) Effect of H1 antihistamines in a model of mesenteric ischaemia/reperfusion. Inflammation Research 57 (Suppl 1), S55-56
98. Collard, C.D. et al. (1999) Complement activation following oxidative stress. Molecular Immunology 36, 941-948 (Pubitemid 30100846)
99. Carden, D.L. and Granger, D.N. (2000) Pathophysiology of ischaemia-reperfusion injury. Journal of Pathology 190, 255-266 (Pubitemid 30141372)
100. Hirahashi, J. et al. (2006) Mac-1 signaling via Src-family and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy. Immunity 25, 271-283 (Pubitemid 44224140)
101. Alexander, J.S. and Elrod, J.W. (2002) Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. Journal of Anatomy 200, 561-574 (Pubitemid 34823048)
102. Chehade, J.M., Haas, M.J. and Mooradian, A.D. (2002) Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochemical Research 27, 249-252 (Pubitemid 34275686)
103. Davidson, M.K. et al. (2000) Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. American Journal of Ophthalmology 129, 267-269 (Pubitemid 30089297)
104. Lee, A.Y. and Chung, S.S. (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB Journal 13, 23-30 (Pubitemid 29038271)
105. Bonnardel-Phu, E. et al. (1999) Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48, 2052-2058 (Pubitemid 29458371)
106. Otero, K. et al. (2001) Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. The Biochemical Journal 359, 567-574 (Pubitemid 33063380)
107. Schmidt, A.M. et al. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochimica et Biophysica Acta 1498, 99-111
108. Yamagishi, S. et al. (2002) Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. Journal of Biological Chemistry 277, 20309-20315 (Pubitemid 34967325)
109. Brownlee, M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625
110. Harrington, E.O. et al. (2003) Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. American Journal of Respiratory Cell and Molecular Biology 28, 626-636 (Pubitemid 36543410)
111. Tinsley, J.H., Teasdale, N.R. and Yuan, S.Y. (2004) Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability. American Journal of Physiology - Cell Physiology 286, C105-111 (Pubitemid 38055818)
112. Yuan, S.Y. et al. (2000) Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circulation Research 87, 412-417
113. Guo, M. et al. (2003) Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiological Genomics 12, 139-146 (Pubitemid 37139693)
114. Caldwell, R.B. et al. (2005) Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Current Drug Targets 6, 511-524 (Pubitemid 40916276)
115. Hashizume, H. et al. (2000) Openings between defective endothelial cells explain tumor vessel leakiness. American Journal of Pathology 156, 1363-1380 (Pubitemid 30660013)
116. Morikawa, S. et al. (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. American Journal of Pathology 160, 985-1000 (Pubitemid 34224587)
117. Piulats, J. and Mitjans, F. (2008) Angiogenesis switch pathways. In Principles of Molecular Oncology (3rd edn) (Bronchud, M.H. et al.), pp. 239-256, Humana Press, Totowa, NJ, USA
118. Anan, K. et al. (1996) Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119, 333-339 (Pubitemid 26082669)
119. Dvorak, H.F. et al. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology 146, 1029-1039
120. Lee, F.Y. et al. (2008) Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models. Clinical Cancer Research 14, 8123-8131
121. Yuan, F. et al. (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/ vascular permeability factor antibody. Proceedings of the National Academy of Sciences of the United States of America 93, 14765-14770 (Pubitemid 26419043)
122. Wu, M.H. (2005) Endothelial focal adhesions and barrier function. Journal of Physiology 569, 359-366
123. Kargozaran, H. et al. (2007) A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clinical and Experimental Metastasis 24, 495-502 (Pubitemid 47524807)
124. Brigham, K.L., Bowers, R.E. and Owen, P.J. (1976) Effects of antihistamines on the lung vascular response to histamine in unanesthetized sheep. Diphenhydramine prevention of pulmonary edema and increased permeability. Journal of Clinical Investigation 58, 391-398
125. Cordeiro, P.G. et al. (2000) Prevention of ischemia-reperfusion injury in a rat skin flap model: the role of mast cells, cromolyn sodium, and histamine receptor blockade. Plastic and Reconstructive Surgery 105, 654-659 (Pubitemid 30111003)
126. Elenkov, I.J. (2004) Glucocorticoids and the Th1/ Th2 balance. Annals of the New York Academy of Sciences 1024, 138-146
127. Svedmyr, N. (1982) Effects of glucocorticoids on the airways. European Journal of Respiratory Diseases (Suppl) 122, 48-53
128. Gerber, H.P. et al. (2000) Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. Cancer Research 60, 6253-6258
129. Zhang, J. et al. (2007) Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer 109, 1478-1486 (Pubitemid 46595681)
130. Aiello, L.P. et al. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proceedings of the National Academy of Sciences of the United States of America 92, 10457-10461
131. Robinson, G.S. et al. (2001) Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB Journal 15, 1215-1217
132. Haritoglou, C. et al. (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26, 999-1005 (Pubitemid 44973218)
133. Whittles, C.E. et al. (2002) ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation 9, 513-522 (Pubitemid 135684861)
134. van Nieuw Amerongen, G.P. and van Hinsbergh, V.W. (2002) Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascular Pharmacology 39, 257-272
135. Gavard, J., Patel, V. and Gutkind, J.S. (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Developmental Cell 14, 25-36
136. Scheppke, L. et al. (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. Journal of Clinical Investigation 118, 2337-2346 (Pubitemid 351872350)
137. Dhainaut, J.F., Yan, S.B. and Claessens, Y.E. (2004) Protein C/activated protein C pathway: overview of clinical trial results in severe sepsis. Critical Care Medicine 32, S194-201
138. Riewald, M. et al. (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882 (Pubitemid 34596276)
139. Bae, J.S. et al. (2007) The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 110, 3909-3916
140. Feistritzer, C. and Riewald, M. (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105, 3178-3184
141. Kurosawa, S., Esmon, C.T. and Stearns-Kurosawa, D.J. (2000) The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. Journal of Immunology 165, 4697-4703
142. Franscini, N. et al. (2004) Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 110, 2903-2909 (Pubitemid 39473616)
143. Joyce, D.E. et al. (2001) Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. Journal of Biological Chemistry 276, 11199-11203 (Pubitemid 38089304)
144. Wong, S.S. et al. (2004) Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1beta in rats. Lung 182, 319-330 (Pubitemid 40685143)
145. Teke, Z. et al. (2008) Activated protein C attenuates intestinal reperfusion-induced acute lung injury: an experimental study in a rat model. American Journal of Surgery 195, 861-873 (Pubitemid 351749444)
146. Aiello, L.P. et al. (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46, 1473-1480 (Pubitemid 27369086)
147. Ishii, H. et al. (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272, 728-731 (Pubitemid 26000279)
148. Koksel, O. et al. (2005) Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632. European Journal of Pharmacology 510, 135-142 (Pubitemid 40312399)
149. Olson, M.F. (2008) Applications for ROCK kinase inhibition. Current Opinion in Cell Biology 20, 242-248
150. Yin, L. et al. (2007) Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Molecular Cancer Therapeutics 6, 1517-1525 (Pubitemid 46954018)
151. Arita, R. et al. (2009) Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes 58, 215-226
152. Peng, F. et al. (2008) RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 57, 1683-1692
153. van Nieuw Amerongen, G.P. et al. (2000) Simvastatin improves disturbed endothelial barrier function. Circulation 102, 2803-2809
154. Zeng, L. et al. (2005) HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation